

Tirzepatide 5mg
A dual GIP/GLP-1 receptor agonist and the most common entry point for metabolic work. Starter vial sized for the first titration steps.
Pricing, lot certificates and the full compound catalogue are released to verified researchers. Enter your email to continue.
Research use only · 21+ · No spam, unsubscribe anytime
$20 CASH BACK FLASH SALE · EVERY ORDER EARNS A $20 CREDIT TOWARD YOUR NEXT ONE · FREE SHIPPING OVER $200
GLP-1, dual and triple receptor agonists plus the metabolic compounds that run alongside them. Every lot assayed by RP-HPLC and confirmed by LC-MS before release.


A dual GIP/GLP-1 receptor agonist and the most common entry point for metabolic work. Starter vial sized for the first titration steps.


The mid-tier vial for anyone already past the starter titration. Covers roughly a full quarter at maintenance dosing.


Highest concentration vial in the range. Built for long maintenance blocks with the fewest shipments and the lowest cost per milligram.


Tirzepatide pre-mixed with methylcobalamin in a ready-to-use solution. The B12 is there to blunt the fatigue people report early in titration.


Double-strength ready-to-use tirzepatide with B12. Suits anyone settled into a stable weekly dose who wants fewer shipments.


The full-quarter ready-to-use vial. Best cost per milligram in the liquid tirzepatide line.



A GLP-1 receptor agonist and the most studied compound in this category. Lyophilised for shelf stability, reconstituted at home.


The standard starting vial. Semaglutide and methylcobalamin already in solution, so week one takes about ninety seconds.


Double-strength ready-to-use semaglutide with B12, for anyone who has finished the first titration block.


The long-block ready-to-use vial. Roughly a full quarter of maintenance dosing in a single shipment.



A triple agonist acting at GIP, GLP-1 and glucagon receptors. The newest compound in the metabolic category and the one people ask about most.


Mid-strength retatrutide for anyone already through the first titration steps.


The full-quarter retatrutide vial and the best value per milligram in the line.


An ERR agonist studied for its effect on mitochondrial output and fat oxidation — often described as an exercise-mimetic pathway.



A mitochondrial-derived peptide involved in metabolic signalling and insulin sensitivity. Commonly stacked with a GLP-1 rather than run alone.


A GHRH analogue with the most clinical data behind it in this category, particularly around visceral adipose tissue.


Double-strength tesamorelin for daily protocols that would otherwise burn through a 5 mg vial every ten days.
Research Use Only. All products sold by MaxSpan Peptides are supplied strictly for in vitro laboratory research by qualified professionals aged 21 or older. They are not intended for human or animal consumption, clinical use, diagnostic use, veterinary application, or any therapeutic purpose. Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. MaxSpan Peptides is a chemical supplier and is not a compounding pharmacy as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, nor an outsourcing facility as defined under Section 503B.